Cellares launches Cell Q

April 19, 2024
The automated cGMP QC Workcell for Cell Therapies, to resolve manual QC processing bottleneck and extend IDMO capabilities from manufacturing through quality control.

Cellares unveiled Cell Q, the automated quality control (QC) workcell for cell therapy manufacturing.

Cell Q addresses a critical challenge: the manual, labor-intensive, low-throughput, and expensive nature of cell therapy QC.

As Cellares Cell Shuttles have addressed upstream bottlenecks in cell therapy manufacturing, Cell Q resolves the downstream QC capacity challenges. Cell Q is engineered to automate the vast majority of cell therapy QC assays for up to 6,000 batches per year. To accelerate analytical method transfer and shorten the time to clinical readout for new IDMO clients, Cell Q includes a pre-qualified set of the most common assays. Additionally, each Cell Q utilizes a modular platform that can be expanded with new instruments providing the flexibility needed to meet varying IDMO client needs. 

Cellares release